Work

Outcomes and responsiveness of standard tyrosine kinase inhibitor dose versus dose de-escalation in chronic myeloid leukemia: A single-center retrospective study.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.6598

Authors: Mark Pusung, Christopher Eide, Andy Kaempf, Nicola Long, Cristina Tognon, Jessica M. Stempel, Diana Brewer, Theodore Paul Braun, Michael C. Heinrich, Brian J. Druker

Institutions: Oregon Health & Science University, OHSU Knight Cancer Institute

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162566673

Cites:

Cited by:

Related to: